Literature DB >> 31120369

Radiation therapy to enhance tumor immunotherapy: a novel application for an established modality.

Eric C Ko1, Silvia C Formenti1.   

Abstract

Purpose: The aim of this review is to highlight key evidence supporting the effect of radiation therapy on tumor immunity. Conclusions: Recent findings in both the preclinical and clinical settings have provided convincing evidence of the ability of radiation therapy to influence tumor-directed immune responses, and have offered critical insights into the underlying mechanisms. Not only does radiation therapy convert the tumor microenvironment to promote robust tumor immunity, but it also enhances the generation of neoantigens and neoepitopes. Radiation therapy also shapes the TCR repertoire of CD8+ T cells in conjunction with immune checkpoint blockade. In conclusion, a high priority should be placed on developing rational strategies to integrate radiation therapy with immunotherapy in the clinical setting, with an emphasis on careful patient selection and identifying important correlative endpoints.

Entities:  

Keywords:  CTLA-4; Radiation therapy; abscopal effect; checkpoint inhibitors; immune checkpoint blockade; immunotherapy; metastatic disease; stereotactic radiation therapy

Mesh:

Substances:

Year:  2019        PMID: 31120369     DOI: 10.1080/09553002.2019.1623429

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  19 in total

1.  An autoimmune-based, paraneoplastic neurologic syndrome following checkpoint inhibition and concurrent radiotherapy for merkel cell carcinoma: case report.

Authors:  Alexander D Sherry; Michael Bezzerides; Mohamed H Khattab; Guozhen Luo; Kristin K Ancell; Austin N Kirschner
Journal:  Strahlenther Onkol       Date:  2020-01-31       Impact factor: 3.621

2.  The prognostic significance of PD-L1 expression on tumor and immune cells in Merkel cell carcinoma.

Authors:  Morgan Guénolé; Paolo Bénigni; Vincent Bourbonne; François Lucia; Delphine Legoupil; Olivier Pradier; Laurent Misery; Arnaud Uguen; Ulrike Schick
Journal:  J Cancer Res Clin Oncol       Date:  2021-06-11       Impact factor: 4.553

3.  Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.

Authors:  Marisa E Aikins; Cheng Xu; James J Moon
Journal:  Acc Chem Res       Date:  2020-10-05       Impact factor: 22.384

4.  Comparative Genomics Reveals Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer.

Authors:  Stephen J Freedland; Kosj Yamoah; Shivanshu Awasthi; Anders Berglund; Julieta Abraham-Miranda; Robert J Rounbehler; Kevin Kensler; Amparo Serna; Adriana Vidal; Sungyong You; Michael R Freeman; Elai Davicioni; Yang Liu; R Jeffrey Karnes; Eric A Klein; Robert B Den; Bruce J Trock; Joshua D Campbell; David J Einstein; Raavi Gupta; Steven Balk; Priti Lal; Jong Y Park; John L Cleveland; Timothy R Rebbeck
Journal:  Clin Cancer Res       Date:  2020-10-09       Impact factor: 13.801

Review 5.  Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses.

Authors:  Niloy R Datta; H Petra Kok; Hans Crezee; Udo S Gaipl; Stephan Bodis
Journal:  Front Oncol       Date:  2020-06-12       Impact factor: 6.244

Review 6.  Altering DNA Repair to Improve Radiation Therapy: Specific and Multiple Pathway Targeting.

Authors:  Julian Biau; Emmanuel Chautard; Pierre Verrelle; Marie Dutreix
Journal:  Front Oncol       Date:  2019-10-10       Impact factor: 6.244

Review 7.  Radiation therapy and the innate immune response: Clinical implications for immunotherapy approaches.

Authors:  Valentí Gómez; Rami Mustapha; Kenrick Ng; Tony Ng
Journal:  Br J Clin Pharmacol       Date:  2020-06-03       Impact factor: 4.335

8.  Circulating immune cell populations related to primary breast cancer, surgical removal, and radiotherapy revealed by flow cytometry analysis.

Authors:  Alessandra Franzetti Pellanda; Curzio Rüegg; Sarah Cattin; Benoît Fellay; Antonello Calderoni; Alexandre Christinat; Laura Negretti; Maira Biggiogero; Alberto Badellino; Anne-Lise Schneider; Pelagia Tsoutsou
Journal:  Breast Cancer Res       Date:  2021-06-05       Impact factor: 6.466

Review 9.  Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma.

Authors:  Zi Mei; Junwen Huang; Bin Qiao; Alfred King-Yin Lam
Journal:  Int J Oral Sci       Date:  2020-05-28       Impact factor: 6.344

Review 10.  Metastasis-directed therapy for oligometastasis and beyond.

Authors:  Thomas H Beckham; T Jonathan Yang; Daniel Gomez; C Jillian Tsai
Journal:  Br J Cancer       Date:  2020-11-18       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.